Parsons awarded $24 million naval medical research command biodefense contract

Chantilly, va., april 07, 2025 (globe newswire) -- parsons corporation (nyse: psn) announced today that the company was awarded a biological defense research contract to advance the naval medical research command's (nmrc) mission to defend against the threat of biological and chemical warfare. the $24 million contract consists of a one-year base period and four one-year option periods.
PSN Ratings Summary
PSN Quant Ranking